Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$328,232
-$1,367,083 QoQ
Shares Held
4,158
-79.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $5,861,764,434 across 35 Diagnostics & Research names. BLLN ranks #33 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,157,226 | $1,551,871,293 | |
| 2 | DHR |
Danaher Corp /De/
|
4,609,288 | $873,921,002 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
387,844 | $489,148,850 | |
| 4 | GH |
Guardant Health, Inc.
|
4,435,839 | $409,738,446 | |
| 5 | A |
Agilent Technologies, Inc.
|
3,577,648 | $407,780,316 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
716,921 | $402,830,739 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,348,694 | $264,317,047 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,177,280 | $200,773,329 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $328,232 | 4,158 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,695,315 | 20,715 | Shares | Defined | 2026-03-25 | |
| No filing history on record for this holder in this stock. | ||||||